Abstract

ABSTRACT

Brugada syndrome was first described in 1992 as right precordial ST-segment elevation in patients with structurally normal hearts and sudden cardiac death. Brugada Syndrome is one of the most common reasons for sudden cardiac death (4-12%) and is a hereditary disease with an autosomal dominant pattern of transmission with nearly 300 pathogenic variants in 19 responsible genes published. The present review focuses on the diagnosis, genetics, risk stratification, and management of patients with Brugada Syndrome.

Alternate abstract:

Brugada sendromu (BrS), ilk olarak 1992 yılında, yapısal kalp hastalığı olmayan ve ani kardi?yak ölüm gelişen hastalarda sağ prekordiyal derivasyonlarda ST segment elevasyonu olarak tanımlanmıştır. BrS, ani kardiyak ölümün en sık nedenlerinden olan (%4-12), otosomal domi?nant geçiş paterni gösteren herediter bir hastalıktır (bilinen 19 gende 300 civarı patojenik vary?ant). Bu derleme, BrS tanısı, genetik değerlendirmesi, risk strafikasyonu ve tedavileri konularını ayrıntılamaktadır.

Details

Title
Recent Status in Brugada Syndrome
Author
Bayrak, Fatih; Brugada, Pedro
Pages
137-144
Section
Review
Publication year
2022
Publication date
Mar 2022
Publisher
Aves Yayincilik Ltd. STI.
ISSN
10165169
e-ISSN
13084488
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2655204893
Copyright
© 2022. This work is published under https://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.